The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Regulation of TGF-β signaling by Smad7
Open accessAbstract
Transforming growth factor (TGF)-beta is a pleiotropic cytokine regulating a variety of cellular processes such as cell growth, differentiation, apoptosis, migration, cell adhesion, and immune response. In the well-understood classical TGF-beta signaling pathway, TGF-beta activates Smad signalling via its two cell surface receptors such as TbetaRII and ALK5/TbetaRI, leading to Smad-mediated transcriptional regulation. In addition, TGF-beta may also activate other signaling pathways like mitogen-activated protein kinase, PI3K, etc. The signaling of TGF-beta is finely regulated at different levels. Inhibitory Smads, including Smad6 and Smad7, are key regulators of TGF-beta/bone morphogenetic protein (BMP) signaling by negative feedback loops. They can form stable complexes with activated type I receptors and thereby blocking the phosphorylation of R-Smads, or recruit ubiquitin E3 ligases, such as Smurf1/2, resulting in the ubiquitination and degradation of the activated type I receptors. Besides, these inhibitory Smad proteins also inhibit TGF-beta/BMP signaling in the nucleus by interacting with transcriptional repressors, such as histone deacetylases, Hoxc-8, and CtBP, or disrupting the formation of the TGF-beta-induced functional Smad-DNA complexes. Smad7 is in turn regulated by different stimuli, including TGF-beta, IFN-gamma, TNF-alpha as well as ultraviolet and TPA, and mediates the crosstalk between TGF-beta and other signaling pathways. Deregulation of Smad7 expression has been associated with various human diseases, such as tissue fibrosis, inflammatory disease as well as carcinogenesis. Overexpression of Smad7 has been shown to antagonize TGF-beta-mediated fibrosis, carcinogenesis, and inflammation, suggesting a therapeutic potential of Smad7 to treat these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
TGF-β: A Master of All T Cell Trades
Li, M. O., & Flavell, R. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.025 · Cited by 893
Li, M. O., Sanjabi, S., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.011 · Cited by 805
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
Hata, A., Lagna, G., Massagué, J., & Hemmati-Brivanlou, A. (1998) · Genes & Development · doi:10.1101/gad.12.2.186 · Cited by 725
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Smad3 as a mediator of the fibrotic response
Flanders, K. C. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.00377.x · Cited by 608
Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
Monteleone, G., Kumberova, A., Croft, N. M., McKenzie, C., Steer, H. W., & MacDonald, T. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12821 · Cited by 600
TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z., & Zhang, Y. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.002 · Cited by 559
Self-citationThe type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C.-H., & Landström, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1780 · Cited by 553
TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Lee, M. K., Pardoux, C., Hall, M. C., Lee, P. S., Warburton, D., Qing, J., Smith, S. M., & Derynck, R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601818 · Cited by 527
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk
members of the CORGI Consortium, Broderick, P., Carvajal-Carmona, L., Pittman, A. M., Webb, E., Howarth, K., Rowan, A., Lubbe, S., Spain, S., Sullivan, K., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.18 · Cited by 514
Mechanisms of TGF-β-mediated apoptosis
Schuster, N., & Krieglstein, K. (2002) · Cell and Tissue Research · doi:10.1007/s00441-001-0479-6 · Cited by 400
Nunes, I., Gleizes, P.-E., Metz, C. N., & Rifkin, D. B. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1151 · Cited by 395
Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ Pathway
He, W., Dorn, D. C., Erdjument-Bromage, H., Tempst, P., Moore, M. A. S., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.03.045 · Cited by 390
Negative regulation of TGF-β receptor/Smad signal transduction
Itoh, S., & ten Dijke, P. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.015 · Cited by 388
Control of Smad7 Stability by Competition between Acetylation and Ubiquitination
Grönroos, E., Hellman, U., Heldin, C.-H., & Ericsson, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00639-1 · Cited by 383
Differentiation plasticity regulated by TGF-β family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature Cell Biology · doi:10.1038/ncb434 · Cited by 382
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Self-citationA tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF‐β signaling
Brown, K. A., Pietenpol, J. A., & Moses, H. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21255 · Cited by 358
Transforming growth factor‐β and Smad signalling in kidney diseases: Review Article
WANG, W., KOKA, V., & LAN, H. Y. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00334.x · Cited by 347
Niemann, C., Owens, D. M., Hülsken, J., Birchmeier, W., & Watt, F. M. (2002) · Development · doi:10.1242/dev.129.1.95 · Cited by 298
GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor
Shi, W., Sun, C., He, B., Xiong, W., Shi, X., Yao, D., & Cao, X. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307151 · Cited by 266
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
Kleeff, J., Ishiwata, T., Maruyama, H., Friess, H., Truong, P., Büchler, M. W., Falb, D., & Korc, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202909 · Cited by 258
Zhang, S., Fei, T., Zhang, L., Zhang, R., Chen, F., Ning, Y., Han, Y., Feng, X.-H., Meng, A., & Chen, Y.-G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-06 · Cited by 255
Self-citationSignaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., & Lan, H. Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121070 · Cited by 236
Kume, S., Haneda, M., Kanasaki, K., Sugimoto, T., Araki, S.-I., Isshiki, K., Isono, M., Uzu, T., Guarente, L., Kashiwagi, A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605904200 · Cited by 233
The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling
Hanyu, A., Ishidou, Y., Ebisawa, T., Shimanuki, T., Imamura, T., & Miyazono, K. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106023 · Cited by 229
Dual role for TGF-?1 in apoptosis
SANCHEZCAPELO, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.11.002 · Cited by 228
Differentiation plasticity regulated by TGF-|[beta]| family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature · doi:10.1038/ncb0907-1000 · Cited by 227
Edlund, S., Bu, S., Schuster, N., Aspenström, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H., & Landström, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0037 · Cited by 226
Ferrigno, O., Lallemand, F., Verrecchia, F., L'Hoste, S., Camonis, J., Atfi, A., & Mauviel, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205623 · Cited by 215
Arkadia amplifies TGF- superfamily signalling through degradation of Smad7
Koinuma, D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg632 · Cited by 215
Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis
Javelaud, D., Mohammad, K. S., McKenna, C. R., Fournier, P., Luciani, F., Niewolna, M., André, J., Delmas, V., Larue, L., Guise, T. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3950 · Cited by 195
Axin is a scaffold protein in TGF‐β signaling that promotes degradation of Smad7 by Arkadia
Liu, W., Rui, H., Wang, J., Lin, S., He, Y., Chen, M., Li, Q., Ye, Z., Zhang, S., Chan, S. C., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601057 · Cited by 193
Self-citationZhao, X., Nicholls, J. M., & Chen, Y.-G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708033200 · Cited by 191
Self-citationThe Balance between Acetylation and Deacetylation Controls Smad7 Stability
Simonsson, M., Heldin, C.-H., Ericsson, J., & Grönroos, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503134200 · Cited by 186
STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling
Datta, P. K., & Moses, H. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3157-3167.2000 · Cited by 175
Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development
Han, G., Li, A. G., Liang, Y.-Y., Owens, P., He, W., Lu, S., Yoshimatsu, Y., Wang, D., ten Dijke, P., Lin, X., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.06.014 · Cited by 163
Brodin, G., Åhgren, A., ten Dijke, P., Heldin, C., & Heuchel, R. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002815200 · Cited by 153
Smad6 as a Transcriptional Corepressor
Bai, S., Shi, X., Yang, X., & Cao, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8267 · Cited by 150
Monteleone, G., Mann, J., Monteleone, I., Vavassori, P., Bremner, R., Fantini, M. C., Blanco, G. D. V., Tersigni, R., Alessandroni, L., Mann, D. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m303654200 · Cited by 148
Hong, S., Lim, S., Li, A. G., Lee, C., Lee, Y. S., Lee, E., Park, S. H., Wang, X., & Kim, S. (2007) · Nature Immunology · doi:10.1038/ni1451 · Cited by 146
Edlund, S., Lee, S. Y., Grimsby, S., Zhang, S., Aspenström, P., Heldin, C., & Landström, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1475-1488.2005 · Cited by 144
Stopa, M., Anhuf, D., Terstegen, L., Gatsios, P., Gressner, A. M., & Dooley, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003282200 · Cited by 140
Smad7 in TGF-β-mediated negative regulation of gut inflammation
Monteleone, G., Pallone, F., & MacDonald, T. T. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.07.008 · Cited by 136
Fine Tuning and Cross-talking of TGF-β Signal by Inhibitory Smads
Park, S. H. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.1.009 · Cited by 133
Choi, K., Lee, Y. S., Lim, S., Choi, H. K., Lee, C., Lee, E., Hong, S., Kim, I.-H., Kim, S., & Park, S. H. (2006) · Nature Immunology · doi:10.1038/ni1383 · Cited by 129
Kim, B.-C., Lee, H.-J., Park, S. H., Lee, S. R., Karpova, T., McNally, J. G., Felici, A., Lee, D. K., & Kim, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2251-2262.2004 · Cited by 120
Smad7 as a therapeutic agent for chronic kidney diseases
Lan, H. Y. (2008) · Frontiers in bioscience · doi:10.2741/3057 · Cited by 119
Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.009 · Cited by 116
Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells
Azuma, H., Ehata, S., Miyazaki, H., Watabe, T., Maruyama, O., Imamura, T., Sakamoto, T., Kiyama, S., Kiyama, Y., Ubai, T., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji399 · Cited by 115
Lin, X., Liang, Y.-Y., Sun, B., Liang, M., Shi, Y. G., Brunicardi, F. C., Shi, Y., & Feng, X. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9081-9093.2003 · Cited by 114
A Nuclear Antagonistic Mechanism of Inhibitory Smads in Transforming Growth Factor-β Signaling
Bai, S., & Cao, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105105200 · Cited by 111
Ohgushi, M., Kuroki, S., Fukamachi, H., O’Reilly, L. A., Kuida, K., Strasser, A., & Yonehara, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10017-10028.2005 · Cited by 109
Mikula, M., Proell, V., Fischer, A. N. M., & Mikulits, W. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20772 · Cited by 107
Evidence for a Role of the JNK Cascade in Smad7-mediated Apoptosis
Mazars, A., Lallemand, F., Prunier, C., Marais, J., Ferrand, N., Pessah, M., Cherqui, G., & Atfi, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101672200 · Cited by 103
Javelaud, D., Delmas, V., Möller, M., Sextius, P., André, J., Ménashi, S., Larue, L., & Mauviel, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208900 · Cited by 101
Quan, T., He, T., Voorhees, J. J., & Fisher, G. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409647200 · Cited by 98
TGFβ induces SIK to negatively regulate type I receptor kinase signaling
Kowanetz, M., Lönn, P., Vanlandewijck, M., Kowanetz, K., Heldin, C., & Moustakas, A. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804107 · Cited by 94
Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts
Wang, B., Omar, A., Angelovska, T., Drobic, V., Rattan, S. G., Jones, S. C., & Dixon, I. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00910.2006 · Cited by 87
Smad7 Stabilizes β-Catenin Binding to E-cadherin Complex and Promotes Cell-Cell Adhesion
Tang, Y., Liu, Z., Zhao, L., Clemens, T. L., & Cao, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800351200 · Cited by 82
Self-citationIwai, T., Murai, J., Yoshikawa, H., & Tsumaki, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801175200 · Cited by 75
AIP4 Restricts Transforming Growth Factor-β Signaling through a Ubiquitination-independent Mechanism
Lallemand, F., Seo, S. R., Ferrand, N., Pessah, M., L'Hoste, S., Rawadi, G., Roman‐Roman, S., Camonis, J., & Atfi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500188200 · Cited by 74
Mochizuki, T., Miyazaki, H., Hara, T., Furuya, T., Imamura, T., Watabe, T., & Miyazono, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313977200 · Cited by 70
Hua, X., Miller, Z., Benchabane, H., Wrana, J. L., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000568200 · Cited by 69
Liu, X., Lee, J., Cooley, M. A., Bhogte, E., Hartley, S., & Glick, A. B. (2003) · PubMed · Cited by 67
Valdimarsdóttir, G., Goumans, M., Itoh, F., Itoh, S., Heldin, C., & ten Dijke, P. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-16 · Cited by 64
Wang, Q., Wei, X., Zhu, T., Zhang, M., Shen, R., Xing, L., O’Keefe, R. J., & Chen, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610997200 · Cited by 63
Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines
Cerutti, J. M., Ebina, K. N., Matsuo, S. E., Martins, L., Maciel, R. M. B., & Kimura, E. T. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345213 · Cited by 61
FKBP12 functions as an adaptor of the Smad7–Smurf1 complex on activin type I receptor
Yamaguchi, T., Kurisaki, A., Yamakawa, N., Minakuchi, K., & Sugino, H. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01966 · Cited by 61
Overexpression of the TGF-β antagonist Smad7 in endometrial cancer
Dowdy, S. C., Mariani, A., Reinholz, M. M., Keeney, G. L., Spelsberg, T. C., Podratz, K. C., & Janknecht, R. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.006 · Cited by 59
Ichijo, T., Voutetakis, A., Cotrim, A. P., Bhattachryya, N., Fujii, M., Chrousos, G. P., & Kino, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509338200 · Cited by 57
Smad7 is required for TGF-β-induced activation of the small GTPase Cdc42
Edlund, S., Landström, M., Heldin, C., & Aspenström, P. (2004) · Journal of Cell Science · doi:10.1242/jcs.01036 · Cited by 57
Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55
Wang, H., Song, K. W., Krebs, T. L., Yang, J., & Danielpour, D. (2008) · Oncogene · doi:10.1038/onc.2008.291 · Cited by 56
Repression of Endogenous Smad7 by Ski
Denissova, N. G., & Liu, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404961200 · Cited by 45
OAZ Regulates Bone Morphogenetic Protein Signaling through Smad6 Activation
Ku, M., Howard, S., Ni, W., Lagna, G., & Hata, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510004200 · Cited by 42
Study of interaction between Smad7 and DNA by single-molecule force spectroscopy
Shi, X., Chen, F., Yu, J., Xu, Y., Zhang, S., Chen, Y., & Fang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.145 · Cited by 27
Self-citationInamoto, S., Iwata, S., Inamoto, T., Nomura, S., Sasaki, T., Urasaki, Y., Hosono, O., Kawasaki, H., Tanaka, H., Dang, N. H., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209848 · Cited by 24
Cited by
Wu, M., Chen, G., & Li, Y.-P. (2016) · Bone Research · doi:10.1038/boneres.2016.9 · Cited by 1,553
TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
Principe, D. R., Doll, J. A., Bauer, J., Jung, B., Munshi, H. G., Bartholin, L., Pasche, B., Lee, C., & Grippo, P. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt369 · Cited by 523
Smith, A. L., Iwanaga, R., Drasin, D. J., Micalizzi, D. S., Vartuli, R. L., Tan, A.-C., & Ford, H. L. (2012) · Oncogene · doi:10.1038/onc.2012.11 · Cited by 293
The role of TGF-β in the pathogenesis of primary open-angle glaucoma
Fuchshofer, R., & Tamm, E. R. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1274-7 · Cited by 288
Diverse Role of TGF-β in Kidney Disease
Gu, Y.-Y., Liu, X.-S., Huang, X.-R., Yu, X.-Q., & Lan, H.-Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00123 · Cited by 257
Metadata
- Authors
- Yan, X., Liu, Z., & Chen, Y.
- Venue
- Acta Biochimica et Biophysica Sinica
- Published
- 2009-04-01
- Volume
- 41
- Issue
- 4
- Pages
- 263-272
- ISSN
- 1672-9145 (ISSN-L)
- OpenAlex
- W2151916930
- Cited by
- 436
- References
- 84
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.